Gregory A. Winchell

1.3k citations

32 papers · 1.1k indexed · h-index 15

Impact in

Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
Virology top 5%
- HIV Research and Treatment

Papers in ⓘ

Infectious Diseases 22
- Antifungal resistance and susceptibility 15
- HIV/AIDS drug development and treatment 7
Pediatrics, Perinatology and Child Health 8
- Pharmaceutical studies and practices 6

Co-authors: Paul Deutsch (11 shared papers)Julie A. Stone (7 shared papers)Howard Greenberg (3 shared papers)Michael Hesney (4 shared papers)Scott A. Waldman (3 shared papers)Kenneth C. Lasseter (6 shared papers)Stacy C. Dilzer (5 shared papers)Goutam C. Mistry (6 shared papers)
Journals: The Journal of Clinical Pharmacology (8 papers)Antimicrobial Agents and Chemotherapy (7 papers)Advances in Therapy (2 papers)Open Forum Infectious Diseases (2 papers)Clinical Pharmacology & Therapeutics (1 paper)
Partner nations: United States Japan Belgium

In The Last Decade

Gregory A. Winchell

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gregory A. Winchell

Since Specialization

Citations

This map shows the geographic impact of Gregory A. Winchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Winchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Winchell more than expected).

Fields of papers citing papers by Gregory A. Winchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Winchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Winchell. The network helps show where Gregory A. Winchell may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory A. Winchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory A. Winchell Line = papers co-authored together Gregory A. Winchell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers Clinical Therapeutics ·Arthur Bergman, Catherine Stevens, Yanyan Zhou, Bingming Yi, Martine E. Laethem, Marina De Smet, Karen Snyder, Deborah Hilliard, Wesley Tanaka, Wei Zeng, Michael Tanen, Amy Q. Wang, Li Chen, Gregory A. Winchell, Michael J. Davies, Steven Ramael, John A. Wagner, Gary Herman	2006	220
2	Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men Antimicrobial Agents and Chemotherapy ·Julie A. Stone, Sherry D. Holland, Peter Wickersham, Andrew Sterrett, Michael S. Schwartz, Cynthia Bonfiglio, Michael Hesney, Gregory A. Winchell, Paul Deutsch, Howard Greenberg, Thomas L. Hunt, Scott A. Waldman	2002	208
3	Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma Antimicrobial Agents and Chemotherapy ·Julie A. Stone, Xin Xu, Gregory A. Winchell, Paul Deutsch, Paul G. Pearson, Elizabeth Migoya, Goutam C. Mistry, Liwen Xi, Alisha Miller, Punam Sandhu, Romi Singh, F A deLuna, Stacy C. Dilzer, Kenneth C. Lasseter	2004	111
4	Potential for Interactions between Caspofungin and Nelfinavir or Rifampin Antimicrobial Agents and Chemotherapy ·Julie A. Stone, Elizabeth Migoya, Lisa Hickey, Gregory A. Winchell, Paul Deutsch, Kalyan Ghosh, Amanda Freeman, Sheng Bi, Rajesh Desai, Stacy C. Dilzer, Kenneth C. Lasseter, Walter K. Kraft, Howard Greenberg, Scott A. Waldman	2004	74
5	A Phase I/II Study of the Protease Inhibitor Indinavir in Children With HIV Infection PEDIATRICS ·Brigitta U. Mueller, John W. Sleasman, Robert P. Nelson, Sharon L. Smith, Paul Deutsch, William Ju, Seth M. Steinberg, Frank M. Balis, Paul Jarosinski, Pim Brouwers, Goutam C. Mistry, Gregory A. Winchell, Sheryl Zwerski, Shizuko Sei, Lauren V. Wood, Steve Zeichner, Philip A. Pizzo	1998	67
6	Pharmacokinetic Profile and Tolerability of Indinavir-Ritonavir Combinations in Healthy Volunteers Antimicrobial Agents and Chemotherapy ·Alfred J. Saah, Gregory A. Winchell, Michael L. Nessly, Melissa A. Seniuk, Rand R. Rhodes, Paul Deutsch	2001	51
7	Single‐ and Multiple‐Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations The Journal of Clinical Pharmacology ·Goutam C. Mistry, Elizabeth Migoya, Paul Deutsch, Gregory A. Winchell, Michael Hesney, Susan Li, Sheng Bi, Stacy C. Dilzer, Kenneth C. Lasseter, Julie A. Stone	2007	49
8	Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial International Journal of Antimicrobial Agents ·Andreas H. Groll, Hisham Abdel‐Azim, Thomas Lehrnbecher, William J. Steinbach, Amanda Paschke, Eric Mangin, Gregory A. Winchell, Hetty Waskin, Christopher Bruno	2020	32
9	Use of In Vitro Drug Metabolism Data to Evaluate Metabolic Drug‐Drug Interactions in Man: The Need for Quantitative Databases The Journal of Clinical Pharmacology ·A. David Rodrigues, Gregory A. Winchell, Michael R. Dobrinska	2001	32
10	Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic Insufficiency The Journal of Clinical Pharmacology ·Gregory A. Winchell, Joyce D. King, C.M. Chavez-Eng, M.L. Constanzer, Scott H. Korn	2002	30
11	Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants The Journal of Clinical Pharmacology ·Elizabeth Migoya, Goutam C. Mistry, Julie A. Stone, Wendy Comisar, Peng Sun, Alisha Norcross, Sheng Bi, Gregory A. Winchell, Kalyan Ghosh, Naoto Uemera, Paul Deutsch, John A. Wagner	2010	27
12	Indinavir and Rifabutin Drug Interactions in Healthy Volunteers The Journal of Clinical Pharmacology ·Walter K. Kraft, Jacqueline B. McCrea, Gregory A. Winchell, Alexandra D. Carides, Richard Lowry, Eric Woolf, Sandra E. Kusma, Paul Deutsch, Howard Greenberg, Scott A. Waldman	2004	27
13	Lack of a pharmacokinetic interaction between indinavir and methadone Clinical Pharmacology & Therapeutics ·Louis R. Cantilena, Jacqueline B. McCrea, D BLAZES, Gregory A. Winchell, A. Carides, C Royce, Paul Deutsch	1999	19
14	Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men. The Journal of Clinical Endocrinology & Metabolism ·Jules I. Schwartz, Anne Van Hecken, P.J. De Schepper, Inge De Lepeleire, Kenneth C. Lasseter, E. Cooper Shamblen, Gregory A. Winchell, M.L. Constanzer, Carlos Chávez, D Z Wang, David L. Ebel, Steven J. Justice, B. J. Gertz	1996	18
15	Drug interactions between caspofungin and tacrolimus JA Stone, Steve Holland, Peter Wickersham, Paul Deutsch, Gregory A. Winchell, Michael Hesney, Rebecca C. Miller, Amanda Freeman, Stacy C. Dilzer, Kenneth C. Lasseter	2001	17
16	Effect of hepatic insufficiency on the pharmacokinetics of caspofungin J. Stone, Steve Holland, S. Li, Peter Wickersham, Paul Deutsch, Gregory A. Winchell, Michael Hesney, Sheng Bi, Marie Friel, Goutam C. Mistry, Stacy C. Dilzer, Kenneth C. Lasseter	2001	12
17	Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hours in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy ·Frank S. Rhame, Sandy Rawlins, Richard A. Petruschke, Tara Erb, Gregory A. Winchell, Helene M. Wilson, Jonathan M. Edelman, Murray A. Abramson	2004	12
18	Finasteride, A Steroid 5α‐Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine The Journal of Clinical Pharmacology ·Gregory A. Winchell, S. Grégoire, Alice Taylor, Janet Hegland, D B Hunninghake	1993	9
19	Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children Antimicrobial Agents and Chemotherapy ·Alina S Bergshoeff, Pieter L. A. Fraaij, Annemarie M. C. van Rossum, Gwenda Verweel, Linda Hawe Wynne, Gregory A. Winchell, Randi Y. Leavitt, Bach Nguyen, Ronald de Groot, David M. Burger	2004	9
20	Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III) Journal of the Pediatric Infectious Diseases Society ·Thomas J. Sferra, Tomáš Merta, Michael Neely, Cláudia Murta de Oliveira, Álvaro Lassaletta, Clàudia Fortuny Guasch, Marcus Dörr, Gregory A. Winchell, Feng-Hsiu Su, Sarah Perko, Doreen Fernsler, Hetty Waskin, Stephen R Holden	2023	9

About Gregory A. Winchell

Gregory A. Winchell is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology, Virology and Plant Science, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (15 papers), HIV/AIDS drug development and treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pharmaceutical studies and practices (6 papers), HIV Research and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Nematode management and characterization studies (4 papers) and Helminth infection and control (4 papers). The work is most often cited by research in Infectious Diseases (684 citations), Virology (116 citations), Small Animals (134 citations), Endocrinology, Diabetes and Metabolism (223 citations) and Pharmacology (224 citations). Gregory A. Winchell has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Paul Deutsch, Julie A. Stone, Howard Greenberg, Michael Hesney, Scott A. Waldman, Kenneth C. Lasseter, Stacy C. Dilzer, Goutam C. Mistry, Elizabeth Migoya and Peter Wickersham. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Advances in Therapy, Open Forum Infectious Diseases and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact